IP Library › Granted Patent US 11,141,056
Granted Patent B2
US 11,141,056 · App. 16/427,709 · Granted Oct 12, 2021

Ophthalmic device

Inventors: Keiichiro Okamoto (Nagoya, JP); Risa Higashita (Nagoya, JP); Chuang Hsin Yuan (Nagoya, JP)
Assignee: TOMEY CORPORATION
A61B3/0025A61B3/102A61B3/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,141,056
App. No.
16/427,709
Granted
Oct 12, 2021
Kind
B2
Abstract

An ophthalmic device that includes an image capturing unit configured to capture a tomographic image of a crystalline lens of a subject eye; a processor; and a memory storing computer-readable instructions therein. The computer-readable instructions, when executed by the processor, may cause the processor to execute: detecting a boundary between tissues in a tomographic image of the crystalline lens of the subject eye captured by the image capturing unit; determining whether the tissues defined by the boundary include an abnormality; and analyzing an analysis item associated with the abnormality.

Claims (17)

1. An ophthalmic device comprising:

an image capturing unit configured to capture a tomographic image of a crystalline lens of a subject eye;

a processor; and

a memory storing computer-readable instructions therein,

wherein

the computer-readable instructions, when executed by the processor, cause the processor to execute:

detecting a boundary between tissues in a tomographic image of the crystalline lens of the subject eye captured by the image capturing unit, wherein the tissues include a nucleus and a tissue different from the nucleus;

determining whether each of the tissues defined by the boundary includes an abnormality; and

for each of at least one of the tissues in which the abnormality is detected, creating a two-dimensional image, the two-dimensional image being a front image of the tissue created by extracting only the tissue in which the abnormality is detected, the front image being an En-face image, and

analyzing an analysis item associated with the abnormality based on the created two-dimensional image.

2. The ophthalmic device according to claim 1 , further comprising a display unit configured to display an analysis result,

wherein when the abnormality is detected, the display unit is configured to display an analysis result of the analysis item.

3. The ophthalmic device according to claim 2 , wherein

when the abnormality is detected in a nucleus of the crystalline lens, the display unit is configured to display the tomographic image of the crystalline lens captured by the image capturing unit by coloring the nucleus of the crystalline lens in a plurality of different colors based on luminance in the tomographic image of the crystalline lens.

4. The ophthalmic device according to claim 1 , wherein

for the nucleus, the two-dimensional image is a tomographic image for the nucleus,

for the tissue different from the nucleus, the two-dimensional image is a front image of the tissue different from the nucleus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: OKAMOTO, KEIICHIRO; HIGASHITA, RISA; HSIN YUAN, CHUANG
To: TOMEY CORPORATION
Reel/Frame 049337/0730 →
Priority Claims (1)
JP JP2018-107209 · Jun 4, 2018 · national
Continuity (1)
Related Publication 20190365218A1 · Dec 5, 2019
Cited By (1)
US 12,543,950